Raab & Moskowitz Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $524K | Hold |
4,144
| – | – | 0.11% | 134 |
|
|
2026
Q1 | $578K | Sell |
4,144
-63
| -1% | -$8.82K | 0.13% | 120 |
|
|
2025
Q4 | $516K | Sell |
4,207
-43
| -1% | -$5.23K | 0.11% | 135 |
|
|
2025
Q3 | $472K | Sell |
4,250
-32
| -0.7% | -$3.64K | 0.11% | 137 |
|
|
2025
Q2 | $475K | Sell |
4,282
-15
| -0.3% | -$1.6K | 0.11% | 134 |
|
|
2025
Q1 | $481K | Hold |
4,297
| – | – | 0.12% | 130 |
|
|
2024
Q4 | $397K | Hold |
4,297
| – | – | 0.1% | 137 |
|
|
2024
Q3 | $360K | Hold |
4,297
| – | – | 0.09% | 142 |
|
|
2024
Q2 | $295K | Sell |
4,297
-150
| -3% | -$10K | 0.08% | 146 |
|
|
2024
Q1 | $326K | Hold |
4,447
| – | – | 0.09% | 142 |
|
|
2023
Q4 | $360K | Sell |
4,447
-243
| -5% | -$18.9K | 0.11% | 131 |
|
|
2023
Q3 | $351K | Buy |
4,690
+175
| +4% | +$13.5K | 0.12% | 124 |
|
|
2023
Q2 | $348K | Hold |
4,515
| – | – | 0.12% | 127 |
|
|
2023
Q1 | $375K | Sell |
4,515
-100
| -2% | -$8.28K | 0.14% | 124 |
|
|
2022
Q4 | $396K | Buy |
4,615
+68
| +1% | +$5.38K | 0.15% | 123 |
|
|
2022
Q3 | $280K | Sell |
4,547
-68
| -1% | -$4.29K | 0.12% | 135 |
|
|
2022
Q2 | $285K | Buy |
4,615
+68
| +1% | +$4.21K | 0.11% | 136 |
|
|
2022
Q1 | $270K | Hold |
4,547
| – | – | 0.09% | 146 |
|
|
2021
Q4 | $330K | Sell |
4,547
-50
| -1% | -$3.44K | 0.11% | 137 |
|
|
2021
Q3 | $321K | Sell |
4,597
-500
| -10% | -$35.1K | 0.12% | 131 |
|
|
2021
Q2 | $351K | Sell |
5,097
-39
| -0.8% | -$2.6K | 0.13% | 121 |
|
|
2021
Q1 | $331K | Buy |
5,136
+253
| +5% | +$16.3K | 0.13% | 123 |
|
|
2020
Q4 | $284K | Sell |
4,883
-253
| -5% | -$15.3K | 0.12% | 125 |
|
|
2020
Q3 | $324K | Buy |
5,136
+143
| +3% | +$9.92K | 0.15% | 111 |
|
|
2020
Q2 | $384K | Sell |
4,993
-159
| -3% | -$12.2K | 0.19% | 105 |
|
|
2020
Q1 | $385K | Sell |
5,152
-47
| -0.9% | -$3.25K | 0.21% | 102 |
|
|
2019
Q4 | $337K | Sell |
5,199
-86
| -2% | -$5.6K | 0.13% | 125 |
|
|
2019
Q3 | $334K | Buy |
5,285
+192
| +4% | +$12.6K | 0.15% | 126 |
|
|
2019
Q2 | $344K | Sell |
5,093
-400
| -7% | -$26.3K | 0.15% | 128 |
|
|
2019
Q1 | $357K | Hold |
5,493
| – | – | 0.16% | 123 |
|
|
2018
Q4 | $343K | Sell |
5,493
-736
| -12% | -$51.4K | 0.17% | 121 |
|
|
2018
Q3 | $480K | Sell |
6,229
-347
| -5% | -$26.2K | 0.2% | 109 |
|
|
2018
Q2 | $465K | Sell |
6,576
-5,080
| -44% | -$359K | 0.22% | 108 |
|
|
2018
Q1 | $878K | Sell |
11,656
-940
| -7% | -$74.7K | 0.43% | 68 |
|
|
2017
Q4 | $902K | Sell |
12,596
-1,285
| -9% | -$97.6K | 0.44% | 71 |
|
|
2017
Q3 | $1.04M | Sell |
13,881
-575
| -4% | -$44K | 0.5% | 64 |
|
|
2017
Q2 | $1.05M | Sell |
14,456
-1,849
| -11% | -$123K | 0.52% | 63 |
|
|
2017
Q1 | $1.11M | Sell |
16,305
-576
| -3% | -$40.5K | 0.58% | 59 |
|
|
2016
Q4 | $1.21M | Sell |
16,881
-1,494
| -8% | -$111K | 0.66% | 52 |
|
|
2016
Q3 | $1.45M | Sell |
18,375
-3,541
| -16% | -$288K | 0.82% | 43 |
|
|
2016
Q2 | $1.83M | Sell |
21,916
-346
| -2% | -$30.7K | 1.04% | 32 |
|
|
2016
Q1 | $2.04M | Sell |
22,262
-1,070
| -5% | -$96.5K | 1.22% | 26 |
|
|
2015
Q4 | $2.36M | Sell |
23,332
-1,856
| -7% | -$193K | 1.41% | 25 |
|
|
2015
Q3 | $2.47M | Buy |
25,188
+601
| +2% | +$66.7K | 1.6% | 19 |
|
|
2015
Q2 | $2.88M | Buy |
24,587
+2,734
| +13% | +$299K | 1.77% | 14 |
|
|
2015
Q1 | $2.15M | Buy |
21,853
+1,617
| +8% | +$164K | 1.3% | 27 |
|
|
2014
Q4 | $1.91M | Sell |
20,236
-1,236
| -6% | -$128K | 1.09% | 32 |
|
|
2014
Q3 | $2.29M | Buy |
21,472
+981
| +5% | +$96.1K | 1.11% | 27 |
|
|
2014
Q2 | $1.7M | Buy |
20,491
+410
| +2% | +$31.9K | 0.81% | 41 |
|
|
2014
Q1 | $1.42M | Buy |
20,081
+75
| +0.4% | +$5.88K | 0.79% | 42 |
|
|
2013
Q4 | $1.5M | Buy |
+20,006
| New | +$1.39M | 0.86% | 42 |
|
Other funds holding GILD
Raab & Moskowitz Asset Management's GILD Position: Q2 2026 in Review
Raab & Moskowitz Asset Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 4,144 shares worth $524K. The position accounts for 0.11% of the portfolio, ranked #134.
Raab & Moskowitz Asset Management first reported a position in GILD in Q4 2013 and has held it in 51 quarters since. The position peaked at $2.88M in Q2 2015. 2,272 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Raab & Moskowitz Asset Management held 4,144 shares of Gilead Sciences worth $524K as of Q2 2026.
- Raab & Moskowitz Asset Management left its Gilead Sciences share count unchanged in Q2 2026.
- Gilead Sciences made up 0.11% of Raab & Moskowitz Asset Management's portfolio in Q2 2026, its #134 holding.
- Raab & Moskowitz Asset Management first reported a position in Gilead Sciences in Q4 2013 and has held it in 51 quarters since.
- Raab & Moskowitz Asset Management's Gilead Sciences position peaked at $2.88M in Q2 2015.
- 2,272 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Raab & Moskowitz Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.